Dr. Sheila Magil, Senior Consultant, will be presenting on the use of Quality by Design (QbD) for Vaccine Development at the 7th Annual ImVacS conference to be held from August 13-16, 2012 in Cambridge, MA. Dr. Magil’s presentation will explore how the use of QbD can determine the design space for seasonal flu vaccines providing a more flexible approach to addressing necessary process changes. A validated design space minimizes the need to use change control documentation for the strain changes required each season. While much of the biopharma industry has been slow to accept this approach, Dr. Magil’s presentation will highlight the benefits of implementing QbD for the manufacture of seasonal flu vaccines which incorporate varying strains each year. Click here to schedule a meeting with Dr. Magil at the conference.